If you're looking for high-growth exposure to some of the most
innovative and fast-growing companies in the U.S., the Nasdaq-100
is a compelling index to consider. Comprised of the largest non-financial
companies listed on the Nasdaq — think Apple, Microsoft, Nvidia, and Amazon —
the Nasdaq-100 offers a tech-heavy growth tilt that many investors favor for
long-term capital appreciation.
For investors using Charles Schwab, there are a few strong routes
to get exposure to the Nasdaq-100 via both ETFs
and mutual funds. Below are some of the top options,
plus pros and tradeoffs to help guide your strategy.
Why the
Nasdaq-100 Is Attractive for Growth Investors
·
Technology
& Innovation Focus: The Nasdaq-100 is dominated by technology and
consumer-discretionary companies, giving high exposure to high-growth themes.
·
Large-cap
Growth: These companies generally have large market capitalizations,
strong cash flows, and the potential for continued expansion.
·
Liquidity
& Diversification: Because many Nasdaq-100 companies are very large and liquid, you
get both the upside of innovation and a diversified basket (across 100
companies) rather than picking individual names.
Top Nasdaq-100 Options on Charles Schwab
Here are some of the top investment vehicles on Schwab for gaining
Nasdaq-100 exposure.
1. Invesco NASDAQ-100 ETF (QQQM)
·
Ticker: QQQM Schwab Wall
Street+2Schwab Wall Street+2
·
Expense Ratio: ~0.15%
annual. Schwab Wall
Street
·
Strategy: This ETF
seeks to track the performance of the Nasdaq-100 Index by investing in the
underlying securities. Schwab Wall
Street
·
Holdings: Includes
top Nasdaq-100 companies like NVIDIA (~9–10%), Apple (~8–9%), Microsoft,
Broadcom, and Amazon. Schwab Wall
Street
·
Advantages:
o Low cost: 0.15% is relatively competitive for a Nasdaq-100 ETF.
o Liquidity & tradability: As an ETF, you can trade it
intraday, making it flexible if you want to tactically adjust.
o Diversified exposure to many of the biggest high-growth companies.
·
Risks /
Considerations:
o Because of
its concentration in large growth tech names, it's exposed to sector risk
(e.g., tech sell-offs, regulation, interest-rate sensitivity).
o As with any
ETF, there can be tracking error vs. the index.
2. Victory NASDAQ-100 Index Fund
(USNQX)
·
Ticker: USNQX Schwab
Brokerage+2Schwab Wall Street+2
·
Structure: This is a mutual fund, not an ETF.
·
Expense Ratio: Around 0.42% for certain share classes. Schwab Wall
Street
·
Strategy: The fund’s
goal is to “match, before fees and expenses, the performance of the stocks
composing the Nasdaq-100.” SEC
It normally invests in most or all of the 100 Nasdaq non-financial companies,
roughly in proportion to their index weightings. SEC
·
Performance: According
to its fund report, it has delivered strong growth over time; for example, a
hypothetical $10,000 investment would have grown significantly (historical data
as of October 2025). Schwab Wall
Street
·
Advantages:
o Mutual-fund structure: Good for automatic investing,
recurring contributions, and potentially long-term holds.
o Index tracking: Gives you exposure very similar to the Nasdaq-100 without having
to buy all 100 individual stocks.
o Simplified reinvestment: As a mutual fund, dividends and
capital gains can be automatically reinvested.
·
Risks /
Considerations:
o Higher expense ratio than the ETF option.
o Non-diversified risk: Since it mirrors the Nasdaq-100, it is exposed to its sector
risks. Also, as per its prospectus, the fund is “non-diversified,” meaning
larger allocations to some big players. SEC
o Mutual fund liquidity: Unlike ETFs, you can only
buy/sell at the end of the trading day (NAV-based), not intraday.
3. Other Potential Options to Explore
·
Invesco QQQ
(QQQ): While not specific to Schwab’s own funds, QQQ is the original,
very liquid Nasdaq-100 ETF. It’s widely available on Schwab. Schwab
Brokerage+1
·
Themed or
factor-based Nasdaq-100 funds: Depending on Schwab’s broader fund list, there may be other ETFs
(e.g., equal-weight or leveraged versions) — but QQQM and USNQX remain among
the core, straightforward plays.
How to Choose Between These Options
Here are some considerations to help you decide which Nasdaq-100
exposure is best for you through Schwab:
1. Investment Style
o If you want
to trade, rebalance, or adjust your exposure frequently, QQQM (ETF) is likely more suitable.
o If you prefer
a more “set it and forget it” investing strategy with recurring contributions, USNQX (mutual fund) may be a better fit.
2. Cost Sensitivity
o ETFS
generally offer lower expense ratios — QQQM’s 0.15% is quite competitive.
o With mutual
funds, you pay for operational and administrative overhead, so USNQX’s costs
are higher.
3. Tax and Account Type
o In a taxable brokerage account, ETFs may offer tax
advantages (capital gains harvesting, flexibility).
o In a retirement account (like an IRA or 401k), mutual
funds can be just as efficient, especially if you’re reinvesting dividends.
4. Risk Tolerance
o The
Nasdaq-100 is growth-oriented and tech-heavy. If you’re comfortable with
volatility and want higher growth potential, it’s a good fit.
o If you're
risk-averse or want to balance your portfolio, you might use Nasdaq-100
exposure as a growth sleeve
alongside more diversified or defensive assets.
5. Liquidity Needs
o ETFs:
Intraday trading → good for tactical or opportunistic trading.
o Mutual Funds:
Only end-of-day NAV → better for long-term investing.
Conclusion
For Charles Schwab investors looking to tap into Nasdaq-100
growth, Invesco QQQM (ETF) and Victory
NASDAQ-100 Index Fund (USNQX) are two highly attractive
options.
·
QQQM is great for
low-cost, liquid exposure — especially if you like the flexibility to trade or
rebalance.
·
USNQX is ideal for
long-term, disciplined investors who prefer mutual funds and want to use
automatic investments.
As always, consider your financial
goals, time horizon,
and risk tolerance when choosing between these. And if
you're not sure which to pick, it may help to run a few scenario analyses — or
even talk to a financial advisor — before building out your Nasdaq-100
allocation.
.png)
No comments:
Post a Comment